Sensitivity, specificity and accuracy of the higher dose of Magnevist® Injection and 2D-TOF MRA for the detection of clinically significant disease Image creation after injection - evaluation at blind read [clinicaltrials_resource:32a614d9f90b46f409b8796a20bf474e]
Single intravenous injection on the study day: lower dose corresponding approx. 0.1 mmol/kg body weight
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Sensitivity, specificity and accuracy of the higher dose of Magnevist® Injection and 2D-TOF MRA for the detection of clinically significant disease Image creation after injection - evaluation at blind read [clinicaltrials_resource:32a614d9f90b46f409b8796a20bf474e]
Single intravenous injection on the study day: lower dose corresponding approx. 0.1 mmol/kg body weight
Bio2RDF identifier
32a614d9f90b46f409b8796a20bf474e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:32a614d9f90b46f409b8796a20bf474e
measure [clinicaltrials_vocabulary:measure]
Sensitivity, specificity and a ...... clinically significant disease
time frame [clinicaltrials_vocabulary:time-frame]
Image creation after injection - evaluation at blind read
description
Single intravenous injection o ...... pprox. 0.1 mmol/kg body weight
identifier
clinicaltrials_resource:32a614d9f90b46f409b8796a20bf474e
title
Sensitivity, specificity and a ...... ion - evaluation at blind read
@en
type
label
Sensitivity, specificity and a ...... 614d9f90b46f409b8796a20bf474e]
@en